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Cells robustly reprogram gene expression during stress generated by protein misfolding
and aggregation. In this condition, cells assemble the bulk of mRNAs into translationally
silent stress granules (SGs), while they sustain the translation of specific mRNAs coding
for proteins that are needed to overcome cellular stress. Alterations of this process are
deeply associated to neurodegeneration. This is the case of amyotrophic lateral sclerosis
(ALS), a neurodegenerative disorder caused by a selective loss of motor neurons. Indeed,
impairment of protein homeostasis as well as alterations of RNA metabolism are now
recognized as major players in the pathogenesis of ALS. In particular, evidence shows
that defective mRNA transport and translation are implicated. Here, we provide a review
of what is currently known about altered mRNA translation in ALS and how this impacts
on the ability of affected cells to cope with proteotoxic stress.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a progressive, adult-onset neurodegenerative disease. The
most significant feature of ALS is the preferential loss of motor neurons from brain and spinal
cord. Yet, a huge heterogeneity characterizes ALS manifestations, and it is now accepted that
ALS is a complex multi-systemic syndrome with important aspects that overlap with other
neurodegenerative disorders (Swinnen and Robberecht, 2014). A wealth of mechanisms has been
suggested to cause ALS pathogenesis, such as protein aggregation, oxidative stress, mitochondrial
damage, excitotoxicity and RNA dys-metabolism (Taylor et al., 2016). Although a big effort is still
needed to clarify whether and to which extent each of these mechanisms play a role, key aspects of
disease pathogenesis have clearly emerged.
The most relevant ALS genes give rise to proteins that accumulate as misfolded and/or
aggregated species inside cells, both as wild-type or mutated forms. Indeed, protein aggregates are
readily found in SOD1-, TDP-43-, FUS- and C9orf72-ALS, the most frequent genetic forms of the
disease. Accordingly, impaired protein homeostasis, a condition that is almost invariably associated
to misfolding and aggregation, has been frequently reported in ALS (Ruegsegger and Saxena,
2016). Moreover, an early and specific induction of endoplasmic reticulum (ER) stress has been
proposed to explain the selective vulnerability of motor neurons (Ng et al., 2015; Sun et al., 2015),
suggesting that these alterations might play a key role in disease pathogenesis. This conclusion is
further supported by the evidence that a number of genes that participate to the autophagic and
proteasomal control of protein degradation, such as ubiquilin-2 (Deng et al., 2011), sequestosome-1
(Fecto et al., 2011), optineurin (Maruyama et al., 2010), valosin-containing protein (VCP; Johnson
et al., 2010), TBK1 (Freischmidt et al., 2015) and VAPB (Chen et al., 2010), are associated
to ALS.
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FUS and TDP-43, as well as other ALS-related genes, have
also a recognized role in the regulation of RNA metabolism,
including RNA transcription and splicing, microRNA processing
and mRNA stability, transport and translation (thoroughly
reviewed in Ratti and Buratti, 2016). Additionally, the expanded
G4C2 hexanucleotide repeat in the C9orf72 gene, the most
frequent genetic mutation in ALS, might impact the proper
regulation of RNA metabolism, as a result of both the
accumulation of RNAs containing the expansion, that might
disrupt the activity of a number of RNA binding proteins
(RBPs), and the expansion-driven production of poly-dipeptides
(dipeptide repeat proteins, DPRs), that accumulate in cells and
affect the proper intracellular trafficking of RNAs (Wen et al.,
2017). Although a specific step of RNA processing that is
predominantly affected in motor neurons has not emerged so
far, mRNA translation might represent a central process in ALS,
as alterations in the control of translation might directly affect
motor neuron functions and their ability to regulate translation
in condition of proteotoxic stress.
ALTERATIONS OF TRANSLATIONAL
CONTROL IN ALS
Protein synthesis is defined by the three classical phases that
include initiation, elongation and termination (Aitken and
Lorsch, 2012; Hinnebusch et al., 2016). Translation initiation
is the rate-limiting step and the most tightly regulated stage,
in which the two ribosomal subunits are assembled into 80S
ribosomes with methionyl-tRNA paired to the mRNA start
codon. In the canonical, cap-dependent translation initiation,
once the GTP-bound form of the eukaryotic initiation factor
eIF2 is loaded with the methionyl-tRNA, it builds the ternary
complex. This binds the small ribosome subunit and generates
the 43S preinitiation complex. Such 43S complex is assembled
on the 5′ mRNA methyl cap by the initiation factor eIF3, with
the contribution of the polyA-binding protein and the eIF4F
complex. This is a crucial step, as mechanisms that inhibit eIF4F
assembly will in turn inhibit translation initiation. Once formed,
the 43S preinitiation complex walks along the mRNA searching
for an initiation AUG codon positioned in the optimal sequence
context that is necessary for the establishing of an effective
48S preinitiation complex. Arrest of the scanning process is
caused by the codon-anticodon recognition, which elicits eIF5B
GAP activity and thereby promoting the hydrolysis of the
GTP in the ternary complex. eIF2-GDP is detached from the
ribosome and this eventually leads to the formation of the 80S
ribosomal complex. Subsequently, translation elongation factors
(eEF) are recruited to promote polypeptide chain extension
until the cycle is ended by the action of stop codon-dependent
termination factors. In this process, the alpha subunit of eIF2 has
a critical role. Indeed, phosphorylation of eIF2α by stress-
induced kinases is the leading mechanism that inhibits the
formation of functional translation initiation complexes and
causes mRNA accumulation into stress granules (SGs; Spriggs
et al., 2010), leading to translational repression of the bulk of
mRNAs in favor of those mRNAs that are required to subside
stress. Recent studies support an intimate relationship between
ALS pathogenesis and protein synthesis: several ALS causative
mutations affect the process of mRNA translation; novel
unconventional and still unveiled translational processes, such as
repeat associated non-AUG (RAN) translation, contribute to the
pathogenesis of ALS.
Defects in mRNA Transport and Local
Translation
Modification of neuronal activity ultimately depends on the
precise localization and turnover of synaptic proteins such as
neurotransmitters, channels, adapters and signaling molecules.
Synaptic accumulation of these proteins is also achieved by
local translation of specific mRNAs peripherally transported by
RNA granules (Krichevsky and Kosik, 2001): ribonucleoprotein
complexes containing ribosomes and temporary translationally
arrested mRNAs, which are locally released and translated in
response to appropriate synaptic stimuli. Several RBPs play a
pivotal role in the assembly and control of RNA transport
granules, by assisting mRNAs in their way from the cell body to
the periphery and modulating their stability and translation.
Evidence suggests a direct association of dysfunctional
neuronal transport granules with ALS. Both TDP-43 and FUS
are found in RNA transport granules (Kanai et al., 2004;
Elvira et al., 2006), and ALS-linked mutant TDP-43 affect
their trafficking (Alami et al., 2014). FMRP, a translational
repressor causally linked to Fragile X Syndrome, also associates
to RNA transport granules, and interacts with TDP-43. FMRP
expression in Drosophila robustly modifies TDP-43-mediated
neurodegeneration. Further, both FMRP and TDP-43 collaborate
to repress the translation initiation of mRNAs encoding proteins
that are essential for synapse formation and plasticity such as
Rac1, GluR1 and Map1b (Majumder et al., 2012, 2016; Coyne
et al., 2014, 2015; Romano et al., 2016). Although the localization
of FUS in motor neuron synaptic terminals has not been
unambiguously clarified, recent findings suggest an involvement
of FUS in the regulation of local translation. In non-neuronal
cells FUS binds to the tumor-suppressor protein adenomatous
polyposis coli (APC), which forms ribonucleoprotein complexes
for targeting mRNAs to cell protrusions, and is required for
efficient local translation of transcripts associated to peripheral
cellular processes (Yasuda et al., 2013). In our previous work,
we demonstrated that FUS carrying ALS causative mutations
physically and genetically interacts with Pur-alpha (Di Salvio
et al., 2015), a DNA-RNA binding protein with several functions,
including the targeting of mRNAs to neuronal dendrites,
as part of RNA transport granules. In particular, Pur-alpha
behaves as a regulator of SG assembly and, together with
FUS, inhibits protein synthesis, participating to FUS toxicity
(Di Salvio et al., 2015). Intriguingly, Pur-alpha also binds
to G4C2 expanded repeats of C9orf72 gene and ameliorates
G4C2-mediated neurodegeneration in Drosophila (Xu et al.,
2013).
RAN Dipeptides and mRNA Translation
Secondary and tertiary structures in the 5′ UTR of
mRNAs strongly affect translation initiation efficiency
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(Green et al., 2016). When these regions are placed downstream
the start codon, they intensely increase translation initiation,
either in the case of suboptimal AUG or even in the total absence
of a start codon (Green et al., 2016). This is particularly relevant
in RAN translation, where translation starts in the absence of
start codon and proceeds at multiple reading frames generating
repeat-containing proteins. Both strands of C9orf72 gene
carrying expanded repeats are actively transcribed, and both
corresponding RNAs are expected to form stable secondary
structures. Accordingly, both transcripts generate different
DPRs by RAN translation: GA, GR, PA, PR and GP. The
molecular machinery that controls RAN translation still needs
to be fully defined (Green et al., 2016). However, recent key
findings indicate that it uses a conventional cap-dependent
ribosomal scanning, but bypasses normal requirements for start
codon selection (Kearse et al., 2016). The formation of DPRs
is widely believed to play a relevant role in C9orf72 toxicity. In
particular, DPRs have been associated with functional alterations
of proteins belonging to RNA transport granules. By analyzing
the DPR interactome, it has clearly emerged, in fact, that the
more toxic dipeptides GR and PR specifically bind to RBPs
of the axonal RNA transport granules and to proteins of the
translational machinery (Tao et al., 2015; Kanekura et al., 2016;
Lee et al., 2016). In particular, GR and PR affect two translation
related pathways: they localize in the nucleolus, where they
block ribosomal RNA synthesis, and they alter SG formation in
the cytoplasm. Further, PR makes complexes with mRNAs and
prevents the access of translation factors (Kanekura et al., 2016),
evidence that underlines, once more, the strong association
between alterations in protein synthesis and the pathogenesis
of ALS.
REGULATION OF TRANSLATION IN
CONDITION OF PROTEOTOXIC STRESS
Stress Granules in ALS
Several of the RBPs connected to ALS localize into SGs.
These are membrane-less, hydrogel-like structures that store
translationally arrested mRNAs that accumulate during cellular
stress, and that rapidly disassemble when stress is removed, in a
process generally referred as ‘‘SG dynamics’’. SGs are composed
by polyadenylated mRNAs, translation initiation factors (eIFs),
small ribosomal subunits and a great number of RBPs (Protter
and Parker, 2016), including ALS-linked RBPs. Among the latter,
FUS and TDP-43 represent the most notable example of proteins
that shuttle from cell nuclei, where they predominantly reside,
into cytosolic SGs in response to a vast array of stress stimuli.
This ability is held by wild type forms of both TDP-43 and
FUS, that readily localize into SGs in stress conditions, and by
ALS-linked mutant forms, that show an enhanced propensity to
coalesce into SGs (Bosco et al., 2010).
In addition to TDP-43 and FUS, also hnRNP A2/B1 and
hnRNPA1 (heterogeneous nuclear ribonucleoprotein A2/B1 and
A1), two RBPs whose mutations are associated to rare forms
of familial ALS (Kim et al., 2013), are part of SGs under stress
conditions. This suggests a role of these two hnRNPs in stress
response that might be impaired, by still unknown mechanisms,
by their mutations (Guil et al., 2006; Martinez et al., 2016).
Further, Ataxin 2, an ALS-linked RBP that causes spinocerebellar
ataxia type 2 (SCA2), is associated to SGs and might have a role
in their assembly (Nonhoff et al., 2007; Kaehler et al., 2012).
However, also non RBP-like ALS factors, that are not obviously
expected to be part of SGs, are indeed found into these structures.
Profilin1, an actin binding protein whose mutations are a rare
cause of familial ALS, localizes into SGs upon induction (Figley
et al., 2014). Furthermore, mutant forms of SOD1, which are
associated to frequent forms of familial ALS, may relocalize to
SGs. Mutant SOD1s bind G3BP1, an RBP that plays important
roles in SGs dynamics, and affect its ability to bind RNAs,
thus interfering with SG assembly. As a result, the formation of
SGs in response to stress is delayed or impaired, with obvious
consequences on cell viability (Gal et al., 2016). Notably, a similar
scenario seems to operate in C9orf72-ALS, where GR and PR
dipeptides promote the spontaneous assembly of SGs and a
consequent inhibition of global protein translation (Wen et al.,
2014; Kanekura et al., 2016; Lee et al., 2016). Both GR and
PR interact with G3BP1, suggesting that the simple interaction
with G3BP1 is sufficient to impair SG dynamics, as in the case
of SOD1 mutations, and that the accumulation of DPRs into
SGs could be not required to alter their function (Lee et al.,
2016).
Therefore, SGs might strongly contribute to ALS
pathogenesis. Yet, how this occurs is still unclear. The tendency
of ALS-related proteins to accumulate into SGs might play
a relevant role in the formation of cytosolic aggregates that
mark the affected tissues in ALS patients. Indeed, the intrinsic
propensity of many RBPs to reversibly associate to each other
(King et al., 2012) might act as a seed for the nucleation of
intracellular aggregates when prolonged stress and/or mutations
occur (Li et al., 2013). Nevertheless, evidence also exists that
aggregates might originate independently (Shelkovnikova et al.,
2014).
However, the association of ALS proteins to SGs supports
a model whereby the disease might be the consequence of a
disturbed SG regulation in both unstressed conditions, when
mutant ALS factors might induce an uncontrolled and sustained
activation of SG-mediated translational repression, or under
stress, when such a response, that is usually strictly and finely
tuned, might escape this regulation. Three lines of evidence
support this model. First, genes that are involved in SG
regulation are potent modifiers of the toxicity of mutant ALS
genes, including TDP-43, Profilin 1 and C9orf72, in yeast and
Drosophila (Couthouis et al., 2011; Kim et al., 2014; Lee et al.,
2016). Second, several ALS-linked genes have a physiological role
in SG formation and dynamics, and the loss of these functions
might be involved in ALS (Aulas et al., 2012, 2015). Last, mutant
ALS proteins might interfere with chaperone-mediated clearance
from SGs of DRiPs, Defective Ribosomal Products constituted
by terminated polypeptides that are released by disassembling
polysomes prior to SG formation. Altered clearance of these
peptides might lead to a decreased rate of SG disassembly, which
further indicates that ALS can be associated with a protracted
state of stress and the consequences of such a state (Ganassi et al.,
2016).
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Role of eIF2α Phosphorylation in ALS
Pathology
Being the key factor in the regulation of SG formation upon
stress conditions, eIF2α has attracted a large interest as a
potential target for interventions aimed at modulating the
stress response that is induced in different neurodegenerative
conditions where proteotoxic stress occurs. Following the
activation of the Unfolded Protein Response (UPR) by
high levels of unfolded or misfolded proteins, the PERK
kinase phosphorylates eIF2α. This decreases the active pool
of the ternary complex with the consequent inhibition of
global translation. This pathway is indeed involved in ALS
pathology, since ER stress markers, including phosphorylated
eIF2α, have been detected in tissues from ALS patients and
animal models (Matus et al., 2013). However, whether the
sustained activation of this response represents a protective
mechanism or has a pathological role is unclear. This issue
is of crucial importance, as it might help in defining whether
enhancing or suppressing eIF2α phosphorylation might be
effective in contrasting the disease. To clarify this issue,
the effects of modulation of eIF2α phosphorylation on
neurodegeneration have been largely investigated in different
disease models.
Genetic approaches have been used to modulate the eIF2α-P
levels inmice overexpressingmutatedG85R-SOD1. In particular,
PERK haploinsufficiency accelerates SOD1misfolding, causes an
earlier disease onset and shortens survival (Wang et al., 2011).
Opposite effects with a marked amelioration of disease were
obtained by expressing in G85R-SOD1 mice an inactive form
of GADD34, the eIF2α-P specific phosphatase (Wang et al.,
FIGURE 1 | Different pathways induced by ALS proteins converge on translational repression. Most of ALS proteins, including mutant SOD1, TDP-43, FUS,
as well as DPRs (poly-dipeptide repeat proteins which are RAN-translated from G4C2 repeat expansion in C9orf72 gene), accumulate as misfolded and/or
aggregated species inside cells (1). Interestingly, these protein aggregates are often found to be positive for stress granules markers suggesting a direct relationship
between these two entities (2). SG formation is strongly associated to translational repression, which is indeed observed in ALS models linked to these genetic forms
(3). Protein aggregates are able to induce ER stress, which is mediated by the activation of PERK kinase which in turn phosphorylates the translational initiation
factor eIF2a (eIF2a-P; 4). eIF2a-P has a central role in cell stress response, since it represses the translation of most cellular mRNA, while promoting the synthesis of
proteins that help to overcome stress, including chaperones. Dephosphorylation of eIF2a, mediated by the phosphatase GADD34, is then essential to turn off this
pathway. Drugs such as GSK2606414, Salubrinal, Guanabenz and Sephin, that act on this mechanism have been tested in models for their therapeutic efficacy,
giving conflicting results. Other ways, which are independent from eIF2a phosphorylation, might be responsible of translational repression induced by ALS proteins.
Indeed, FUS and TDP-43 are both RNA-binding proteins involved in RNA transport as part of RNA transport granules, and ALS-associated mutations might affect the
proper localization and translation of specific mRNAs (such as Rac1, GluR1 and Map1b) that are important for neuromuscular junction (NMJ) structure and function
(5). Moreover, C9orf72 RNA foci sequester eIF2a, which might be less available for mRNA translation, thus resulting in translational inhibition and stress response (6).
Finally, both repeat RNA foci and DPRs cause mRNA export defects, thus leading to the retention of mRNAs in cell nuclei and their reduced cytoplasmic availability
(7). DPRs have been also found to directly bind mRNAs, making them less accessible to translation initiation factors, thus inhibiting protein translation (8).
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2014a). In line with these results, pharmacological treatment of
SOD1-G93A mice with Salubrinal, Guanabenz, or its derivative
Sephin, all inhibitors of eIF2α de-phosphorylation, delays disease
progression and prolongs survival (Saxena et al., 2009; Wang
et al., 2014b; Das et al., 2015). Altogether, these data indicate
that UPR has an important role in SOD1-mediated ALS,
and support the idea that the induction of UPR and the
prolonged activation of eIF2α phosphorylation are beneficial
to motor neuron survival, which is in line with the notion
that stress response is essential for cell survival. However,
in Drosophila the knockdown of PERK or GADD34 fly
homologs respectively suppresses or enhances motility defects
caused by TDP-43 toxicity (Kim et al., 2014). Moreover, a
significant rescue of TDP-43 toxicity is observed in Drosophila
and in primary rat cortical neurons followed by treatment
with a specific PERK inhibitor (GSK2606414; Kim et al.,
2014). The inhibition of the UPR pathway is also beneficial
in other misfolding-related diseases, such as Prion Disease,
Frontotemporal Dementia and Alzheimer (Moreno et al.,
2012, 2013; Ma et al., 2013; Devi and Ohno, 2014; Radford
et al., 2015). Taken together, these observations converge
on the idea that while a transient eIF2α phosphorylation
is essential to overcome stress conditions, the persistent
expression of eIF2α-P and the associated translational repression
could be detrimental for neuronal viability and contribute
to the pathogenic mechanisms. Moreover, they indicate that
in ALS other pathways that converge on the regulation of
protein translation might be activated together with, or even
independently frommisfolding-induced stress andmight explain
the different response to eIF2α-P targeting. In particular, this is
suggested by the actual role that ALS factors such as TDP-43
and FUS might have in the control of protein translation,
as previously mentioned, but also by the observation that
stress response seems to be readily activated in C9orf72 ALS
even in the absence of a clear phosphorylation of eIF2α.
Indeed, accumulation of C9orf72 repeats causes a general
impairment in nucleo-cytosol shuttling of RNAs (Freibaum
et al., 2015; Rossi et al., 2015), leading to an entrapment in
cell nuclei of polyadenylated mRNAs, which would be therefore
less available for cytosolic translation. Interestingly, similar
conclusions were drawn in cultured cells expressing arginine-
containing polypeptides (PR and GR), that bind mRNAs and
interfere with eIF4F assembly, thus inhibiting protein translation
in the absence of enhanced eIF2α phosphorylation (Kanekura
et al., 2016).
In conclusion, an increasing amount of genetic and
mechanistic indications point to alterations in the proper control
of mRNA translation as critical players in ALS pathogenesis
(Figure 1). Clearly, further investigations are needed to better
define whether and to which extent protein misfolding and
aggregation are the actual trigger of these events, how mutations
affect the ability of ALS-linked genes to regulate mRNA transport
and local protein synthesis, and how the therapeutic potential of
targeting mRNA translation regulation can be converted into an
effective treatment in different ALS conditions.
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